Rellon, Baby Boy .

HRN: 27-15-78  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/28/2025
AMPICILLIN 250MG (VIAL)
05/28/2025
06/03/2025
IV
37 Mg
Q12H
Preterm Newborn
Waiting Final Action 
05/28/2025
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
05/28/2025
06/03/2025
IV
12 Mg
Q48H
Preterm Newborn
Waiting Final Action 
05/30/2025
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
05/30/2025
06/06/2025
IV
11.5mg As LD 5.5mg As MD
Q12
Gastrointestinal Infection
Waiting Final Action 
06/01/2025
CEFOTAXIME 500MG (VIAL)
06/01/2025
06/07/2025
IV
22 Mg
Q12H
RDS; NEC
Remove - Pending Acceptance

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: